These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4724006)

  • 1. [A new treatment for reduced tear production].
    Tiburtius H; Merker HJ
    Klin Monbl Augenheilkd; 1973 Apr; 162(4):535-9. PubMed ID: 4724006
    [No Abstract]   [Full Text] [Related]  

  • 2. [A method of treating conjunctivitis sicca and Sjögren's disease with a secretolytic].
    Grosse-Ruyken FJ
    Klin Monbl Augenheilkd; 1973 Apr; 162(4):540-3. PubMed ID: 4724007
    [No Abstract]   [Full Text] [Related]  

  • 3. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome.
    Tsubota K; Fujita H; Tadano K; Takeuchi T; Murakami T; Saito I; Hayashi Y
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):101-10. PubMed ID: 11133854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of keratoconjunctivitis sicca using bromhexine-containing eye drops and bromhexine capsules].
    Neubauer O
    Wien Med Wochenschr; 1973 Dec; 123(48):719-22. PubMed ID: 4752629
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of bromhexin on the functional deficiency of the lacrimal apparatus and the salivary glands in Sjogren's syndrome].
    Isager H; Frost-Larsen K; Manthorpe R; Westergaard L
    Med Monatsschr; 1977 Dec; 31(12):582-3. PubMed ID: 593225
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of lacrimal deficiencies. Mechanical devices.
    Doane MG
    Int Ophthalmol Clin; 1973; 13(1):239-44. PubMed ID: 4724260
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of physalaemin in the treatment of Sjogren's disease].
    Tamborini A; Perrotta P
    Ann Ottalmol Clin Ocul; 1969 Dec; 95(12):945-60. PubMed ID: 5408524
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of physalaemine on lacrimal and salivary secretion in Sjögren's syndrome].
    Sala G; Cortellaro M; Ballabio CB
    Reumatismo; 1968; 20(5):594-6. PubMed ID: 5736354
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of topical Healon tears in the management of refractory dry-eye syndrome.
    DeLuise VP; Peterson WS
    Ann Ophthalmol; 1984 Sep; 16(9):823-4. PubMed ID: 6508097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low-molecular weight sodium hyaluronate in the treatment of tear film changes and of dry eye].
    Bohm E; Rama P; Tallandini L; Leardini G; de Carli MA
    Ophtalmologie; 1988 Oct; 2(4):353-4. PubMed ID: 3247207
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of immunosuppressive drugs on the morphology of the microvilli in Sjögren's syndrome.
    Scharf JM; Meyer E; Scharf JA; Nahir M; Zonis S
    Scand J Rheumatol Suppl; 1986; 61():215-9. PubMed ID: 3473634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ultrastructural study of the lacrimal gland in Gougerot-Sjögren syndrome].
    Chomette G; Liotet S; Auriol M; Bellefqih S; Laroche L
    Arch Anat Cytol Pathol; 1985; 33(3):149-54. PubMed ID: 4037878
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.
    Klinngam W; Janga SR; Lee C; Ju Y; Yarber F; Shah M; Guo H; Wang D; MacKay JA; Edman MC; Hamm-Alvarez SF
    Sci Rep; 2019 Jul; 9(1):9559. PubMed ID: 31267034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A histopathologic study on lacrimal gland in Sjögren's syndrome].
    Kong LP; Fei PF; Gong YH
    Zhonghua Yan Ke Za Zhi; 1994 Nov; 30(6):434-6. PubMed ID: 7774460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histology of the lacrimal gland in keratoconjunctivitis sicca.
    Williamson J; Gibson AA; Wilson T; Forrester JV; Whaley K; Dick WC
    Br J Ophthalmol; 1973 Nov; 57(11):852-8. PubMed ID: 4785251
    [No Abstract]   [Full Text] [Related]  

  • 16. Alternate-day steroid therapy for patients with primary Sjögren's syndrome.
    Tabbara KF; Frayha RA
    Ann Ophthalmol; 1983 Apr; 15(4):358-61. PubMed ID: 6660708
    [No Abstract]   [Full Text] [Related]  

  • 17. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
    Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
    Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial of bromhexine in Sjögren's syndrome.
    Avisar R; Savir H; Machtey I; Ovaknin L; Shaked P; Menache R; Allalouf D
    Ann Ophthalmol; 1981 Aug; 13(8):971-3. PubMed ID: 7027873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of human tear proteins--2. Analysis by crossed immunoelectrophoresis of tears from diseased eyes.
    Inada K; Baba H; Okamura R
    Jpn J Ophthalmol; 1983; 27(2):277-88. PubMed ID: 6620714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lacrimal gland in Sjögren's syndrome.
    Sato EA; Matsumoto Y; Dogru M; Kaido M; Wakamatsu T; Ibrahim OM; Obata H; Tsubota K
    Ophthalmology; 2010 May; 117(5):1055-1055.e3. PubMed ID: 20438979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.